4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-012348
Senior Vice President and CFO gave up 12,308 shares (to pay taxes)
- Senior Vice President and CFO acquired 36,455 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-16 | Exercise or conversion : show line 1 in the form | +23,955 | $3.78 | $90,550 | 141,268 | D |
| 2017-03-16 | Exercise or conversion : show line 2 in the form | +12,500 | $1.42 | $17,750 | 153,768 | D |
| 2017-03-16 | Shares withheld for taxes : show line 3 in the form | −12,308 | $8.80 | $108,310 | 141,460 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-03-16 | Exercise or conversion : show line 4 in the form Emp. Stock Option (Right to Buy) | −23,955 | $3.78 | 2021-07-01 | 23,955 | 59,055 | D |
| 2017-03-16 | Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) | −12,500 | $1.42 | 2023-01-01 | 12,500 | 75,000 | D |
Loading xslF345X03/form4.xml…